NeuroGenetic Pharmaceuticals' Unattributed VC Round

NeuroGenetic Pharmaceuticals raised a round of funding on December 23, 2011. Investors include AbbVie Biotech Ventures.

Neurogenetic Pharmaceuticals is a biopharmaceutical discovery and development company focused on developing drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer's d…

Articles about NeuroGenetic Pharmaceuticals' Unattributed VC Round: